[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2018112A6 - Un procedimiento de preparacion de derivados de 4h-1-benzopiran-4-ona o sus sales. - Google Patents

Un procedimiento de preparacion de derivados de 4h-1-benzopiran-4-ona o sus sales.

Info

Publication number
ES2018112A6
ES2018112A6 ES8903465A ES8903465A ES2018112A6 ES 2018112 A6 ES2018112 A6 ES 2018112A6 ES 8903465 A ES8903465 A ES 8903465A ES 8903465 A ES8903465 A ES 8903465A ES 2018112 A6 ES2018112 A6 ES 2018112A6
Authority
ES
Spain
Prior art keywords
same
benzopyran
salt
producing
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES8903465A
Other languages
English (en)
Inventor
Shuntaro Takano
Chosaku Yoshida
Takahiro Inaba
Keiichi Tanaka
Ryuko Takeno
Hideyoshi Nagaki
Tomoya Shimotori
Shinji Makino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyama Chemical Co Ltd
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of ES2018112A6 publication Critical patent/ES2018112A6/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/34—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
    • C07D311/36—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only not hydrogenated in the hetero ring, e.g. isoflavones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/42—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4
    • C07D311/44—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 with one hydrogen atom in position 3
    • C07D311/54—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 with one hydrogen atom in position 3 substituted in the carbocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/42—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4
    • C07D311/56—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 without hydrogen atoms in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

UN PROCEDIMIENTO DE PREPARACION DE DERIVADOS DE 4H-1-BENZOPIRAN-4-ONA O SUS SALES. COMPRENDE: HACER REACCIONAR UN COMPUESTO DE FORMULA (II) O UNA SAL DEL MISMO, CON UN DERIVADO REACTIVO DEL COMPUESTO DE FORMULA RBS1SOSI3H, PARA PRODUCIR UN COMPUESTO DE FORMULA (I) O UNA SAL DEL MISMO. EN ESTAS FORMULAS, LOS DIFERENTES SIMBOLOS RESPRESETAN DIVERSOS RADICALES ORGANICOS. ESTOS COMPUESTOS TIENEN APLICACION EN EL TRATAMIENTO DE LA INFLAMACION SIN PRODUCCION DE EFECTOS ULCEROGENICOS.
ES8903465A 1987-10-08 1989-10-13 Un procedimiento de preparacion de derivados de 4h-1-benzopiran-4-ona o sus sales. Expired - Fee Related ES2018112A6 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP25425187 1987-10-08
JP11999088 1988-05-17
JP63250811A JPH0753725B2 (ja) 1987-10-08 1988-10-06 ４ｈ―１―ベンゾピラン―４―オン誘導体およびその塩、それらの製造法並びにそれらを含有する抗炎症剤

Publications (1)

Publication Number Publication Date
ES2018112A6 true ES2018112A6 (es) 1991-03-16

Family

ID=27313952

Family Applications (8)

Application Number Title Priority Date Filing Date
ES8803062A Expired - Fee Related ES2013801A6 (es) 1987-10-08 1988-10-07 Procedimiento de preparacion de derivados de 4h-1-benzopiran-4-ona o sus sales.
ES8903468A Expired - Fee Related ES2017839A6 (es) 1987-10-08 1989-10-13 Procedimiento de preparacion de derivados de 4h-1-benzopiran-4-ona o sus sales>
ES8903464A Expired - Fee Related ES2017836A6 (es) 1987-10-08 1989-10-13 Procedimiento de preparacion de derivados de 4h-1-benzopiran-4-ona o sus sales.
ES8903466A Expired - Fee Related ES2017837A6 (es) 1987-10-08 1989-10-13 Un procedimiento de preparacion de derivados de 4h-1-benzopiran-4-ona o sus sales.
ES8903465A Expired - Fee Related ES2018112A6 (es) 1987-10-08 1989-10-13 Un procedimiento de preparacion de derivados de 4h-1-benzopiran-4-ona o sus sales.
ES8903463A Expired - Fee Related ES2018111A6 (es) 1987-10-08 1989-10-13 Procedimiento de preparacion de derivados de 4h-1-benzopiran-4-ona o sus sales.
ES8903467A Expired - Fee Related ES2017838A6 (es) 1987-10-08 1989-10-13 Un procedimiento de preparacion de derivados de 4h-1-benzopiran-4-ona o sus sales.
ES8903469A Expired - Fee Related ES2018113A6 (es) 1987-10-08 1989-10-13 Procedimiento de preparacion de derivados de 4h-1-benzopiran-4-ona o sus sales.

Family Applications Before (4)

Application Number Title Priority Date Filing Date
ES8803062A Expired - Fee Related ES2013801A6 (es) 1987-10-08 1988-10-07 Procedimiento de preparacion de derivados de 4h-1-benzopiran-4-ona o sus sales.
ES8903468A Expired - Fee Related ES2017839A6 (es) 1987-10-08 1989-10-13 Procedimiento de preparacion de derivados de 4h-1-benzopiran-4-ona o sus sales>
ES8903464A Expired - Fee Related ES2017836A6 (es) 1987-10-08 1989-10-13 Procedimiento de preparacion de derivados de 4h-1-benzopiran-4-ona o sus sales.
ES8903466A Expired - Fee Related ES2017837A6 (es) 1987-10-08 1989-10-13 Un procedimiento de preparacion de derivados de 4h-1-benzopiran-4-ona o sus sales.

Family Applications After (3)

Application Number Title Priority Date Filing Date
ES8903463A Expired - Fee Related ES2018111A6 (es) 1987-10-08 1989-10-13 Procedimiento de preparacion de derivados de 4h-1-benzopiran-4-ona o sus sales.
ES8903467A Expired - Fee Related ES2017838A6 (es) 1987-10-08 1989-10-13 Un procedimiento de preparacion de derivados de 4h-1-benzopiran-4-ona o sus sales.
ES8903469A Expired - Fee Related ES2018113A6 (es) 1987-10-08 1989-10-13 Procedimiento de preparacion de derivados de 4h-1-benzopiran-4-ona o sus sales.

Country Status (16)

Country Link
US (1) US4954518A (es)
JP (1) JPH0753725B2 (es)
KR (1) KR910007970B1 (es)
AT (1) AT397088B (es)
AU (1) AU605363B2 (es)
BE (1) BE1002226A5 (es)
CA (1) CA1320959C (es)
CH (1) CH679397A5 (es)
DE (1) DE3834204A1 (es)
ES (8) ES2013801A6 (es)
FI (1) FI98460C (es)
FR (1) FR2621585B1 (es)
GB (1) GB2210879B (es)
IT (1) IT1235048B (es)
NL (1) NL194914C (es)
SE (1) SE468595B (es)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3924417A1 (de) * 1989-07-24 1991-01-31 Merck Patent Gmbh Chromanderivate
EP0419410A3 (en) * 1989-09-19 1991-08-14 Ciba-Geigy Ag Alkanophenones
EP0549729B1 (en) * 1990-09-07 1997-12-17 Schering Corporation Antiviral compounds and antihypertensive compounds
FR2695387B1 (fr) * 1992-09-09 1994-10-21 Adir Nouveaux composés benzopyraniques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
PT695547E (pt) * 1993-04-09 2001-12-28 Toyama Chemical Co Ltd Imunomodulador inibidor da adesao celular e agente para tratamento e prevencao de doencas auto-imunes
WO1995033462A1 (en) * 1994-06-02 1995-12-14 Smithkline Beecham Corporation Anti-inflammatory compounds
IT1288123B1 (it) 1996-09-04 1998-09-10 Nicox Sa Uso di nitroderivati per l'incontinenza urinaria
ID24166A (id) 1997-11-19 2000-07-13 Kowa Co Turunan piridazin baru dan obat-obatan yang mengandung hal yang sama sebagai ramuan efektif
TWI241295B (en) 1998-03-02 2005-10-11 Kowa Co Pyridazine derivative and medicine containing the same as effect component
US6649645B1 (en) * 1998-12-23 2003-11-18 Pharmacia Corporation Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia
JP2000247959A (ja) 1999-02-26 2000-09-12 Kowa Co ピリダジン−３−オン誘導体及びこれを含有する医薬
JP2001055331A (ja) * 1999-06-11 2001-02-27 Toyama Chem Co Ltd アトピー性皮膚炎治療剤
US6664256B1 (en) 2000-07-10 2003-12-16 Kowa Co., Ltd. Phenylpyridazine compounds and medicines containing the same
GB0119865D0 (en) * 2001-08-14 2001-10-10 Cancer Res Campaign Tech DNA-PK inhibitors
GB0119863D0 (en) * 2001-08-14 2001-10-10 Cancer Res Campaign Tech DNA-PK inhibitors
AR038957A1 (es) 2001-08-15 2005-02-02 Pharmacia Corp Terapia de combinacion para el tratamiento del cancer
JP3972663B2 (ja) * 2002-01-22 2007-09-05 松下電器産業株式会社 高周波信号受信装置
US7049313B2 (en) * 2002-02-25 2006-05-23 Kudos Pharmaceuticals Ltd. ATM inhibitors
DK1511734T3 (da) 2002-04-17 2010-08-02 Cytokinetics Inc Forbindelser, præparater og fremgangsmåder
JP4828822B2 (ja) * 2002-05-24 2011-11-30 ミレニアム ファーマシューティカルズ， インコーポレイテッド Ｃｃｒ９インヒビターおよびその使用方法
DE60326248D1 (de) * 2002-07-17 2009-04-02 Cytokinetics Inc Verbindungen, zusammensetzungen und verfahren zur behandlung von zellulären proliferativen erkrankungen
EP1554265A4 (en) * 2002-09-13 2008-05-07 Cytokinetics Inc COMPOSITIONS, COMPOSITIONS AND M THODES
US7227035B2 (en) * 2002-11-18 2007-06-05 Chemocentryx Bis-aryl sulfonamides
US20070021466A1 (en) * 2002-11-18 2007-01-25 Solomon Ungashe CCR2 inhibitors and methods of use thereof
US7741519B2 (en) * 2007-04-23 2010-06-22 Chemocentryx, Inc. Bis-aryl sulfonamides
US7420055B2 (en) * 2002-11-18 2008-09-02 Chemocentryx, Inc. Aryl sulfonamides
ATE363470T1 (de) 2002-11-18 2007-06-15 Chemocentryx Inc Arylsulfonamide
DE10256182A1 (de) * 2002-12-02 2004-06-24 Merck Patent Gmbh 2-Oxadiazolchromonderivate
US20070287844A1 (en) * 2003-03-14 2007-12-13 Toyama Chemical Co., Ltd. Novel Crystal of N-[3-(Formylamino)-4-Oxo-6-Phenoxy-4h-Chromene-7-Yl] Methanesulfonamide
MXPA05009972A (es) * 2003-03-18 2005-11-04 Kowa Co Derivado de fenilpiridazina soluble en agua y medicina que contiene el mismo.
CN100387231C (zh) * 2003-03-24 2008-05-14 天津药物研究院 一种制备古拉替莫固体制剂的工艺及其固体制剂
ES2341342T3 (es) * 2003-08-13 2010-06-18 Kudos Pharmaceuticals Limited Aminopironas y su uso como inhibidores de atm.
WO2005042697A2 (en) * 2003-10-06 2005-05-12 Cytokinetics, Inc. Compounds, compositions and methods
TW200616986A (en) * 2004-09-20 2006-06-01 Kudos Pharm Ltd DNA-pk inhibitors
TW200638938A (en) * 2005-02-09 2006-11-16 Kudos Pharm Ltd ATM inhibitors
AR054438A1 (es) * 2005-04-15 2007-06-27 Kudos Pharm Ltd Inhibidores de adn -pk
KR100704009B1 (ko) * 2005-08-30 2007-04-04 한국화학연구원 염증억제 활성을 가지는6-알킬아미노-2-메틸-2'-(ｎ-메틸치환술폰아미도)메틸-2ｈ-1-벤조피란 유도체
US20070049588A1 (en) * 2005-08-31 2007-03-01 Kudos Pharmaceuticals Limited Atm inhibitor
CN101891726B (zh) * 2005-10-09 2012-05-23 天津药物研究院 艾拉莫德结晶形态及其组合物
CN101885718B (zh) * 2005-10-09 2012-05-23 天津药物研究院 艾拉莫德结晶形态及其组合物
CN101885717B (zh) * 2005-10-09 2012-05-23 天津药物研究院 艾拉莫德结晶形态及其组合物
JP4788955B2 (ja) * 2006-01-13 2011-10-05 住友金属工業株式会社 鉄道車両における操舵用アクチュエータの制御方法
AU2006233256B2 (en) * 2006-10-30 2012-01-19 Armaron Bio Pty Ltd Improved flavonols
US7960567B2 (en) * 2007-05-02 2011-06-14 Amgen Inc. Compounds and methods useful for treating asthma and allergic inflammation
UY31232A1 (es) * 2007-07-19 2009-03-02 Compuestos derivados de dibenzotifenilamino-cromen-4-onas activas sustituidas y sus isomeros y aplicaciones
JP5828235B2 (ja) 2011-07-21 2015-12-02 新日鐵住金株式会社 鉄道車両用操舵台車
JP5802868B2 (ja) 2013-07-18 2015-11-04 富山化学工業株式会社 マクロファージ遊走阻止因子の阻害作用に基づく疾患の治療剤
CN107021891A (zh) * 2017-04-24 2017-08-08 常州佳德医药科技有限公司 一种艾拉莫德中间体的制备方法
CN106986797B (zh) * 2017-04-24 2018-09-28 常州佳德医药科技有限公司 N-(2-(4-乙酰苯氧基)-5-甲氧基苯基)甲磺酰胺及其制备方法
CN111170914B (zh) * 2018-11-09 2021-12-21 成都大学 硒/硫化磺酰芳胺类化合物及其硒/硫化方法
CN109705000A (zh) * 2019-02-26 2019-05-03 南京红杉生物科技有限公司 艾拉莫德中间体及其合成方法
WO2021241725A1 (ja) * 2020-05-29 2021-12-02 富士フイルム富山化学株式会社 高純度のｎ－（５－メトキシ―２－フェノキシフェニル）メタンスルホンアミド及びその製造方法
CN113968838B (zh) * 2020-07-25 2024-04-02 华创合成制药股份有限公司 一种硫代苯并吡喃类化合物及其在类风湿性关节炎治疗中的应用
CN113968836A (zh) * 2020-07-25 2022-01-25 华创合成制药股份有限公司 一种苯并吡喃衍生物及其在类风湿性关节炎治疗中的应用
CN114539104A (zh) * 2022-03-09 2022-05-27 常州佳德医药科技有限公司 一种艾拉莫德中间体的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3661990A (en) * 1970-04-13 1972-05-09 Riker Laboratories Inc N-alkylsulfonyl benzoylhaloalkylsulfonanilides
US3689523A (en) * 1971-01-04 1972-09-05 Minnesota Mining & Mfg Substituted haloalkanesulfonanilides
US3840597A (en) * 1971-02-24 1974-10-08 Riker Laboratories Inc Substituted 2-phenoxy alkane-sulfonanilides
GB1499323A (en) * 1974-03-22 1978-02-01 Fisons Ltd 6-substituted chromones and chromanones
DE2537204A1 (de) * 1974-08-23 1976-03-04 Fisons Ltd Neue benzopyrane und verfahren zu ihrer herstellung
DE2965279D1 (en) * 1978-07-27 1983-06-01 Schering Ag Indanyl derivatives, process for their preparation and pharmaceutical compositions containing these compounds
DE3110009A1 (de) * 1981-03-11 1982-09-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue benzofuran-derivate, ihre herstellung und verwendung
DE3208079A1 (de) * 1982-03-04 1983-09-08 Schering AG, 1000 Berlin und 4709 Bergkamen Neue indanyl-derivate, ihre herstellung und verwendung
FR2543140B1 (fr) * 1983-03-24 1985-06-21 Cortial Nouveaux acides flavone-carboxyliques-4', leur methode de preparation et leur application en therapeutique
DE3343331A1 (de) * 1983-11-28 1985-06-05 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur herstellung von indanyl-derivaten und deren verwendung
US4713393A (en) * 1985-04-25 1987-12-15 Merck & Co., Inc. Phenylpropyl-2,3-dihydrobenzofurans useful as anti-inflammatory agents
PT86407B (pt) * 1986-12-31 1990-11-20 Fujisawa Pharmaceutical Co Processo para a preparacao de novos derivados de alcano-sulfonanilida, e de composicoes farmaceuticas compreendendo os mesmos

Also Published As

Publication number Publication date
GB8823567D0 (en) 1988-11-16
FI98460C (fi) 1997-06-25
FR2621585B1 (fr) 1994-01-28
ES2018113A6 (es) 1991-03-16
ES2013801A6 (es) 1990-06-01
CA1320959C (en) 1993-08-03
IT1235048B (it) 1992-06-17
AT397088B (de) 1994-01-25
FR2621585A1 (fr) 1989-04-14
FI884626A (fi) 1989-04-09
NL8802464A (nl) 1989-05-01
CH679397A5 (es) 1992-02-14
SE8803570D0 (sv) 1988-10-07
NL194914C (nl) 2003-07-04
AU2348988A (en) 1989-04-13
AU605363B2 (en) 1991-01-10
GB2210879A (en) 1989-06-21
ATA249588A (de) 1993-06-15
KR910007970B1 (ko) 1991-10-05
ES2017837A6 (es) 1991-03-01
DE3834204C2 (es) 1992-04-23
JPH0753725B2 (ja) 1995-06-07
BE1002226A5 (fr) 1990-10-23
KR890006610A (ko) 1989-06-14
IT8848441A0 (it) 1988-10-10
FI98460B (fi) 1997-03-14
ES2017839A6 (es) 1991-03-01
JPH0249778A (ja) 1990-02-20
SE8803570L (sv) 1989-04-09
GB2210879B (en) 1991-09-18
FI884626A0 (fi) 1988-10-07
NL194914B (nl) 2003-03-03
US4954518A (en) 1990-09-04
DE3834204A1 (de) 1989-04-20
ES2017836A6 (es) 1991-03-01
ES2018111A6 (es) 1991-03-16
ES2017838A6 (es) 1991-03-01
SE468595B (sv) 1993-02-15

Similar Documents

Publication Publication Date Title
ES2017836A6 (es) Procedimiento de preparacion de derivados de 4h-1-benzopiran-4-ona o sus sales.
ES2013067A6 (es) Un procedimiento para producir un derivado de piperazina.
NL980012I1 (nl) Mometasonfuroaat-monohydraat, werkwijze om zulks te bereiden en farmaceutische samenstellingen.
HUT61989A (en) Process for producing 2-deoxy-2,3-didehydro-n-acetylneuraminic acid derivatives and analogs, as well as pharmaceutical compositions comprising same as active ingredient
HUT59400A (en) Process for producing thiazole acylamino derivatives substituted with heterocyclic group, as well as pharmaceutical compositions comprising such compounds as active ingredient
RU93049997A (ru) Производные метилен-бис-фосфоновой кислоты, способ их получения, фармацевтическая композиция
HUT47123A (en) Process for producing phosphorous compounds and pharmaceutical compositions comprising them as active ingredient, as well as their intermediates
ES476106A1 (es) Procedimiento para la preparacion de 4-espectinomicilamina.
HUT57197A (en) Process for producing iminothiazoline derivatives and their intermediates, as well as herbicidal compositions comprising iminothiazoline derivatives as active ingredient
ES8301928A1 (es) Un procedimiento para preparar 4-(2-4-dicloro-3-metilbenzoil)-1,3-dimetil-5-fenaciloxipirazol).
RU2091378C1 (en) 7-acyl-3-substituted carbamoylhydroxycephems, methods of their synthesis, substituted carbamoylhydroxy-3-cephems, methods of their synthesis and antibacterial composition
HUT56579A (en) Process for producing 19-norprogesterone derivatives alkylated at 17/21 position, as well as pharmaceutical compositions comprising such compounds as active ingredient
ES8305319A1 (es) "procedimiento para la preparacion de acidos antranilicos sustituidos con radicales basicos"
HUT52111A (en) Process for producing cytidine-5'-diphosphatealkanols and -glycerine derivatives, as well pharmaceutical compositions comprising such compounds as active ingredient
ES8707194A1 (es) Un metodo para producir derivados de trihaloimidazol

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20081008